AI is revolutionizing the pharmaceutical industry by addressing the high costs, long timelines, and low success rates of traditional drug development. The technology is now integrated into key stages of drug discovery, from target identification to automated synthesis, significantly improving efficiency and success rates. The AI pharmaceutical market is projected to grow substantially, reaching approximately $2.49 billion in 2025 and potentially exceeding $46 billion by 2035, with China expected to be a significant growth market. AI
IMPACT AI integration in drug discovery promises to accelerate development cycles and reduce costs, potentially leading to faster breakthroughs in new medicines.
RANK_REASON The item is a research report analysis from CITIC Securities about the impact of AI on the pharmaceutical industry, not a direct release or product launch.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
